Sustained weight loss exceeding 100 kg with sequential incretin-based therapy in Prader–Willi syndrome
Marlon Yovera-Aldana, Helard Manrique-Hurtado, Guillermo E Umpierrez · 2026
Read Sustained weight loss exceeding 100 kg with sequential incretin-based therapy in Prader–Willi syndrome by Marlon Yovera-Aldana, Helard Manrique-Hurtado, Guillermo E Umpierrez (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13579046.txt.
Description
Marlon Yovera-Aldana, Helard Manrique-Hurtado, and Guillermo Umpierrez report in 2026 a striking case of weight loss in Prader-Willi syndrome. This genetic condition is marked by relentless hunger and severe obesity, and lasting weight loss is almost unheard of in it.
Their patient, a twenty-nine-year-old man, began treatment at one hundred eighty-five kilograms with newly found type 2 diabetes. A sequence of incretin-based drugs, the gut-hormone medicines behind modern weight loss therapy, was given over time. He lost more than one hundred kilograms and kept the loss off. The case hints that even the most stubborn genetic obesity may yield to these drugs.
Catalog record
| CREATOR | Marlon Yovera-Aldana, Helard Manrique-Hurtado, Guillermo E Umpierrez |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 19 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |